seizures

home run
Biotech

Xenon epilepsy candidate 'blows away' ph. 3 expectations

Xenon plans to submit azetukalner for FDA approval later this year, and analysts believe it could become the new standard of care.
Darren Incorvaia Mar 9, 2026 10:55am
Lightbulb with an image of a brain inside

Bright Minds anti-seizure candidate shines in phase 2 win

Jan 6, 2026 10:38am
colorful brain art model

Praxis sees success in ph. 2 seizure trial, setting up FDA push

Dec 5, 2025 10:00am
A baby inside of an incubator

Ceribell nets FDA nod for detecting seizures in preterm newborns

Nov 26, 2025 9:49am
rocket ship blast off fire away take off

Rapport's seizure drug hits in phase 2, sending stock soaring

Sep 8, 2025 8:25am
White arrow on a road pointing to the rising sun

Praxis' drug reduces seizures but sees 23% discontinuation rate

Aug 4, 2025 10:22am